Navigation Links
Study of neighborhoods points to modifiable factors, not race, in cancer disparities
Date:4/12/2009

While cities have shown considerable racial disparities in cancer survival, those racial disparities virtually disappear among smaller populations, such as neighborhoods within that city. The finding comes from a new analysis published in the May 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study examined breast and prostate cancer survival rates at different geographic levels, and the results suggest that there are significant societal factors at the root of cancer-related racial disparities.

Previous research has shown that considerable health disparities exist relating to race, ethnicity, geographic location, and other factors. While researchers have been striving to understand the causes of such disparities in survival from some cancers, including cancers of the breast and prostate, the potential roles of innate factors, such as genetic differences, versus modifiable factors, such as socioeconomic differences, remain unclear.

Researchers led by Jaymie Meliker, Ph.D. of Stony Brook University investigated if these disparities remained among different population sizesfor example whether disparities seen in counties persisted in cities and even neighborhoods. They studied regions in Michigan, drawing from the Michigan Cancer Surveillance Program, which compiled information from 1985-2002 on 124,218 breast cancer and 120,615 prostate cancer patients.

The team's goal was to conduct an analysis of racial disparities in cancer survival at different geographic scales. As the geographic scale decreases, the population becomes more homogenous in terms of socioeconomic status and other characteristics, such as proximity to medical screening facilities. Therefore, the researchers hypothesized that if racial disparities diminished when smaller geographic areas were analyzed, modifiable factors, not biology, may be responsible for the disparity.

The study revealed that whites experienced significantly higher survival rates for prostate and breast cancer compared with blacks throughout much of southern Michigan when large geographic regions were analyzed. However, when the investigators analyzed smaller geographic regions, such as legislative districts and community-defined neighborhoods, disparities diminished or virtually disappeared.

"When racial disparities vanish in small geographic areas, it suggests that modifiable factors are responsible for apparent racial disparities observed at larger geographic scales," the authors write. These modifiable factors could include socioeconomic factors, differences in tumor stage, differences in treatment and the presence of additional health conditions. It is unclear which of these are important, but this study's findings suggest that genetic factors are not likely to play a large role in disparities of survival from prostate and breast cancer.


'/>"/>

Contact: Claire Greenwell
claire.greenwell@cancer.org
404-417-5883
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... ... A prescription medication bottle, pocket knife, luggage and a solar-powered aluminum casting ... Challenge , the Cradle to Cradle Products Innovation Institute has announced. , ... run through early 2018. The challenges are presented by the Institute in partnership with ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare company ... clinical study for its dental gel that shows significant reduction in plaque levels and ... triclosan. The study was conducted at the Beckman Laser Institute at UC Irvine and ...
(Date:1/17/2017)... ... , ... Many people make New Year’s resolutions or renew their commitment to better health with ... for people who want to kick off 2017 with better smiles. Dr. Mondavi is offering ... special offers include: , , A new patient package for just ...
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... 2017 , ... Houston dentist, Dr. Behzad Nazari, announces that ... and financing for orthodontics for a limited time. Complimentary for a limited time, ... orthodontic options. Walk-in, late-evening, Saturday, and same-day appointments are available. Antoine Dental also ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... diagnostic tests and pathology services for evaluating risks of ... dated January 13, 2017 from the NASDAQ Listing Qualifications ... the requirement of the NASDAQ Stock Market to maintain ... The letter noted that for the last ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... ... laparotomy sponges market to grow at a CAGR of 7.94% during ... 2016-2020, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:1/17/2017)... 2017 Tempus, a technology company focused ... Hospitals Seidman Cancer Center have joined together to ... advanced molecular analysis and clinical decision support tools ... providers. As part of the ... sequencing and analysis for ovarian and triple negative ...
Breaking Medicine Technology: